Skip to content

Comparative study between different Homoeopathic potency scales in the treatment of Tinea Corporis in adolescents.

Different Homoeopathic Potency Scales in managing the cases of Tinea corporis in Adolescent Age Group: A Comparative Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/05/042552
Enrollment
66
Registered
2022-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

Intervention1: Homoeopathic Medicine in Group A: Comparative Study between 50 Millesimal Potency Group and Centesimal Potency Group Oral Route of administration 50 Millesimal Potency in Liquid Form

Sponsors

Bakson Homoeopathic Medical College Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age group from 10-19 years. Both male and female. Subjects presenting with clinical symptoms of Tinea Corporis given in ICD-10-CM code B35.4 and diagnosed with Direct Microscopic examination through Potassium Hydroxide mount. Patients already on allopathic medication/ topical agents for Tinea Corporis will be included after 15 days of washout period.

Exclusion criteria

Exclusion criteria: Patient with negative KOH findings. Patients with Tinea Capitis, Tinea Cruris, Tinea Pedis and Onychomycosis. Complications of Tinea Corporis (Lichenification and Ezematization) and conditions like Seborrheic Dermatitis, Pityriasis Rosea and Psoriasis. Patient receiving Homeopathic treatment for any chronic condition within last 6 months. Patients with psychiatric diseases, and those who are not able to comply to the study protocol.

Design outcomes

Primary

MeasureTime frame
There will be significant difference between 50 Millesimal Scale and centesimal scale potencies using 12- item Pruritus Severity Scale which will be used in managing cases of Tinea corporisTimepoint: 5 months of enrollment 6 months of treatment & follow up 1 month of Analysis Total 12 Months

Secondary

MeasureTime frame
There will be significant difference in the results of KOH findings between both the groupsTimepoint: 5 months enrollment 6 months treatment & Follow up 1 month Analysis Total 12 Months

Countries

India

Contacts

Public ContactDr C P Sharma

Bakson Homoeopathic Medical College & Hospital

1995.aparnasingh@gmail.com9654689839

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026